Medicare Enrolled
Dr. Mohammed Seedat, M.D.
Critical Care Medicine · Rome, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Seedat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seedat?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Seedat
Dr. Mohammed Seedat is a critical care medicine specialist in Rome, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Seedat performed 1,966 Medicare services across 1,126 unique beneficiaries.
Between the years covered by Open Payments, Dr. Seedat received a total of $11,026 from 44 pharmaceutical and/or device companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Seedat is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in NY
$11,026 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,966
Medicare services
Top 10% in NY for critical care medicine
1,126
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~103 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
555 | $60 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
464 | $54 | $126 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
249 | $91 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $88 | $205 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
155 | $132 | $310 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
50 | $8 | $76 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
38 | $7 | $49 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $77 | $220 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
30 | $127 | $308 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
29 | $90 | $428 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
28 | $62 | $110 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
26 | $94 | $461 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
24 | $9 | $42 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
23 | $97 | $248 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
17 | $14 | $30 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
14 | $6 | $49 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $54 | $95 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
13 | $10 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
13 | $36 | $88 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
12 | $35 | $93 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,026
Total received (2018-2024)
Avg $1,575/year across 7 years
Top 11% in NY for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
623
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,989 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,188
2023
$1,822
2022
$1,795
2021
$1,837
2020
$1,216
2019
$1,883
2018
$1,284
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
HARMONY BIOSCIENCES LLC
$200
Electromed, Inc.
$178
GlaxoSmithKline, LLC.
$174
Grifols USA, LLC
$142
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
AstraZeneca Pharmaceuticals LP
$97
Philips North America LLC
$49
Takeda Pharmaceuticals U.S.A., Inc.
$48
GENZYME CORPORATION
$44
INOGEN, INC.
$42
Mylan Specialty L.P.
$35
Neurocrine Biosciences, Inc.
$27
Teva Pharmaceuticals USA, Inc.
$22
Insmed, Inc.
$14
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,177
Grifols USA, LLC
$1,243
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,236
AstraZeneca Pharmaceuticals LP
$1,072
Electromed, Inc.
$839
Mylan Specialty L.P.
$650
Philips Electronics North America Corporation
$327
Bayer HealthCare Pharmaceuticals Inc.
$324
Janssen Pharmaceuticals, Inc
$269
Insmed, Inc.
$262
PFIZER INC.
$222
Takeda Pharmaceuticals U.S.A., Inc.
$211
HARMONY BIOSCIENCES LLC
$200
GENZYME CORPORATION
$198
Genentech USA, Inc.
$174
Mallinckrodt Hospital Products Inc.
$160
JAZZ PHARMACEUTICALS INC.
$143
Teva Pharmaceuticals USA, Inc.
$142
Regeneron Healthcare Solutions, Inc.
$140
Jazz Pharmaceuticals Inc.
$126
Baxter Healthcare
$117
Paratek Pharmaceuticals, Inc.
$94
SK Life Science, Inc.
$85
E.R. Squibb & Sons, L.L.C.
$74
Neurocrine Biosciences, Inc.
$58
Philips North America LLC
$49
Mallinckrodt Enterprises LLC
$45
Acorda Therapeutics, Inc
$42
INOGEN, INC.
$42
Sunovion Pharmaceuticals Inc.
$33
Mallinckrodt LLC
$28
Pulmonx Corporation
$23
CSL Behring
$23
Harmony Biosciences LLC
$22
United Therapeutics Corporation
$21
Novartis Pharmaceuticals Corporation
$20
ADVANCED RESPIRATORY, INC
$20
Actelion Pharmaceuticals US, Inc.
$19
Nestle HealthCare Nutrition Inc.
$18
Merck Sharp & Dohme LLC
$18
Biohaven Pharmaceutical Holding Company Ltd.
$17
Advanced Respiratory, Inc
$16
Merck Sharp & Dohme Corporation
$15
Nabriva Therapeutics, plc
$12
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · Adempas · AirDuo Digihaler · Arikayce · Austedo XR · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CUTAQUIG · DUPIXENT · ELIQUIS · Esbriet · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INBRIJA · INGREZZA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Kcentra · LONHALA MAGNAIR · NUCALA · NURTEC ODT · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · PANZYGA · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · WAKIX · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xenleta · Xolair · YUPELRI · Yupelri · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
3
Per 100K population
1.3
County median income
$68,819
Nearest hospital
ROME MEMORIAL HOSPITAL, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Seedat is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NY), with low-engagement industry engagement in the top 11% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Seedat experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Seedat performed 555 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seedat receive payments from pharmaceutical companies?
Yes. Dr. Seedat received a total of $11,026 from 44 companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seedat's costs compare to other critical care medicines in Rome?
Dr. Seedat's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seedat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Rome
Browse critical care medicines in Rome ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in NY
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in NY
Which NY critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology